Fukushima N - Search Results

1

Aberrant methylation of Reprimo correlates with genetic instability and predicts poor prognosis in pancreatic ductal adenocarcinoma.

Sato N, Fukushima N, Matsubayashi H, Iacobuzio-Donahue CA, Yeo CJ, Goggins M. Sato N, et al. Among authors: fukushima n. Cancer. 2006 Jul 15;107(2):251-7. doi: 10.1002/cncr.21977. Cancer. 2006. PMID: 16752411 Free article.

2

Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.

Fukushima N, Sato N, Ueki T, Rosty C, Walter KM, Wilentz RE, Yeo CJ, Hruban RH, Goggins M. Fukushima N, et al. Am J Pathol. 2002 May;160(5):1573-81. doi: 10.1016/S0002-9440(10)61104-2. Am J Pathol. 2002. PMID: 12000709 Free PMC article.

3

Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas.

Sato N, Ueki T, Fukushima N, Iacobuzio-Donahue CA, Yeo CJ, Cameron JL, Hruban RH, Goggins M. Sato N, et al. Among authors: fukushima n. Gastroenterology. 2002 Jul;123(1):365-72. doi: 10.1053/gast.2002.34160. Gastroenterology. 2002. PMID: 12105864

4

Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features.

Okusaka T, Okada S, Ueno H, Ikeda M, Shimada K, Yamamoto J, Kosuge T, Yamasaki S, Fukushima N, Sakamoto M. Okusaka T, et al. Among authors: fukushima n. Cancer. 2002 Nov 1;95(9):1931-7. doi: 10.1002/cncr.10892. Cancer. 2002. PMID: 12404287 Free article.

5

Aberrant methylation of the 5' CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs.

Jansen M, Fukushima N, Rosty C, Walter K, Altink R, Heek TV, Hruban R, Offerhaus JG, Goggins M. Jansen M, et al. Among authors: fukushima n. Cancer Biol Ther. 2002 May-Jun;1(3):293-6. doi: 10.4161/cbt.84. Cancer Biol Ther. 2002. PMID: 12432281 Free article.

6

Diagnosing pancreatic cancer using methylation specific PCR analysis of pancreatic juice.

Fukushima N, Walter KM, Uek T, Sato N, Matsubayashi H, Cameron JL, Hruban RH, Canto M, Yeo CJ, Goggins M. Fukushima N, et al. Cancer Biol Ther. 2003 Jan-Feb;2(1):78-83. doi: 10.4161/cbt.183. Cancer Biol Ther. 2003. PMID: 12673124 Free article.

7

Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues.

Matsubayashi H, Sato N, Fukushima N, Yeo CJ, Walter KM, Brune K, Sahin F, Hruban RH, Goggins M. Matsubayashi H, et al. Among authors: fukushima n. Clin Cancer Res. 2003 Apr;9(4):1446-52. Clin Cancer Res. 2003. PMID: 12684418

8

Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays.

Sato N, Fukushima N, Maitra A, Matsubayashi H, Yeo CJ, Cameron JL, Hruban RH, Goggins M. Sato N, et al. Among authors: fukushima n. Cancer Res. 2003 Jul 1;63(13):3735-42. Cancer Res. 2003. PMID: 12839967

9

Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma.

Sato N, Maitra A, Fukushima N, van Heek NT, Matsubayashi H, Iacobuzio-Donahue CA, Rosty C, Goggins M. Sato N, et al. Among authors: fukushima n. Cancer Res. 2003 Jul 15;63(14):4158-66. Cancer Res. 2003. PMID: 12874021

10

SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions.

Sato N, Fukushima N, Maehara N, Matsubayashi H, Koopmann J, Su GH, Hruban RH, Goggins M. Sato N, et al. Among authors: fukushima n. Oncogene. 2003 Aug 7;22(32):5021-30. doi: 10.1038/sj.onc.1206807. Oncogene. 2003. PMID: 12902985

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,215 results

Search Page

Filters